robert f kennedy jr glp 1 Weight-loss drugs could set up clash between RFK and aides RFK Jr. considering 'framework' for

The market is growing due to increasing diabetes prevalence and government healthcare initiatives aimed at improving access to treatments

Unlike GLP-1-only treatments such as Wegovy, which primarily reduce appetite, retatrutide also directly stimulates fat metabolism through its action on glucagon receptors

Regular maintenance treatments can help prolong results

Fatigue, recovery and wellbeing In the post-exercise setting, meta-analyses have been published that suggest a possible reduction in muscle pain and some markers such as myoglobin or creatine kinase under certain conditions, although the magnitude of the effect and applicability depend on the protocol (Kaazeminasab et al, 2025)

Semaglutide had a 42% lower risk of worsening mental health, while liraglutide was linked to an 18% lower risk

The economics of pharmaceutical development do create real evidence gaps for unpatentable molecules, and patients pay the cost of that asymmetry